Login
$SRXH
$1.04 -$0.03 (2.8%) Close

$SRXH SEC Filings

Filed On Filing
07 Oct 2026 8-K: Entry into a Material Definitive Agreement

This STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of October 6, 2026, is made by and among CERo Therapeutics Holdings, Inc., a Delaware corporation (“Seller”), and SRX Global Inc., a Delaware corporation formerly known as SRX He...

06 Oct 2026 8-K: Regulation FD Disclosure

SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim

09 Sep 2026 8-K: Entry into a Material Definitive Agreement

This Limited Consent and Amendment Agreement (the “Agreement”), dated as of September 8, 2026, is by and between SRX Global Inc., a Delaware corporation (the “Company”), and the holder identified on the signature page hereto (the “Holder”).

02 Sep 2026 8-K: Entry into a Material Definitive Agreement
28 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
19 Aug 2026 8-K: Results of Operations and Financial Condition
13 Aug 2026 10-Q
29 Jul 2026 8-K/A: Unregistered Sales of Equity Securities

As previously announced, on March 16, 2026, SRX Global Inc. (f/k/a SRx Health Solutions, Inc.), a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accre...

28 Jul 2026 8-K: Unregistered Sales of Equity Securities
21 Jul 2026 8-K: Entry into a Material Definitive Agreement
16 Jul 2026 424B3
16 Jul 2026 424B3
16 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
15 Jul 2026 8-K: Regulation FD Disclosure
10 Jul 2026 8-K: Regulation FD Disclosure
08 Jul 2026 SCHEDULE 13G/A
06 Jul 2026 S-8
26 Jun 2026 8-K: Regulation FD Disclosure
25 Jun 2026 SCHEDULE 13G
24 Jun 2026 DEFR14C

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support